Phytochemistry, Pharmacology, and Toxicity of Medicinal Plants

A special issue of Plants (ISSN 2223-7747). This special issue belongs to the section "Phytochemistry".

Deadline for manuscript submissions: 31 December 2025 | Viewed by 1090

Special Issue Editors


E-Mail
Guest Editor
College of Agriculture and Environmental Science (CAES), University of South Africa, PrivaBagX06, Florida 0710, South Africa
Interests: medicinal plants used in the management of a plethora of both human and animal diseases; both curable and incurable

E-Mail Website
Guest Editor
1. The Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Beijing, China
2. Peking Union Medical College, Beijing, China
Interests: phytochemistry: investigation of bioactive metabolites from traditional medicinal plants; fungal chemistry: investigation of secondary metabolites from endophytic fungi collected from special environments such as desert or grasslands; biosynthesis: investigation of biosynthetic pathways of fungal secondary metabolites with complex structures and important bioactivities

Special Issue Information

Dear Colleagues,

The use of medicinal plants in treating various devastating human and animal diseases is ancient. It is still important today due to many illnesses requiring sophisticated instruments, extraordinary antibiotics, and management to extend human life. Such diseases are further compounded by the many microbes that have developed resistance to the antibiotics commonly used in health facilities. Although some plants, along with their characterized bioactive compounds, exert important biological effects that include antimicrobial, antioxidant, anti-inflammatory, anticancer, antiparasitic, antidiabetic, and various enzyme inhibition activities in vitro, both distinctive compounds and the mode of action of such plant-based resources remain unknown, if not unstudied. Some state-of-the-art instruments such as nuclear magnetic resonance (NMR), liquid chromatography (LC-MS), gas chromatography–mass spectrometry, and high-pressure liquid chromatography are essential in mapping out the possible phytocompounds responsible for such pharmacological activities, either individually or in a synergistic manner. The toxicological aspects of such plant-based products, which may include cytotoxicity and heavy metal contaminations, are also of paramount importance to ascertain the safety profile that would be required to produce over-the-counter products. Additionally, the biosynthesis of most secondary metabolites from medicinal plants including biosynthetic pathways, key enzymic functions in the pathways, transcriptomic analysis and specific regulators and others are not investigated. This Special Issue calls for papers addressing the pharmacology of less studied and rare medicinal plants from around the world, the phytochemistry of their extracts and or fractions and the possibility of identifying isolated compounds, and the biosynthesis of bioactive constituents of medicinal plants.

Dr. Nkoana Mongalo
Prof. Dr. Gang Ding
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Plants is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • phytochemistry
  • ethnomedicinal uses
  • pharmacological activity
  • GC-MS
  • LC-MS
  • NMR
  • biosynthesis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 2810 KiB  
Article
Anticonvulsant Potential and Toxicological Profile of Verbesina persicifolia Leaf Extracts: Evaluation in Zebrafish Seizure and Artemia salina Toxicity Models
by Carlos Alberto López-Rosas, Santiago González-Periañez, Tushar Janardan Pawar, Jorge Iván Zurutuza-Lorméndez, Fernando Rafael Ramos-Morales, José Luís Olivares-Romero, Margarita Virginia Saavedra Vélez and Fabiola Hernández-Rosas
Plants 2025, 14(7), 1078; https://doi.org/10.3390/plants14071078 - 1 Apr 2025
Viewed by 374
Abstract
Epilepsy is a chronic neurological disorder with significant treatment challenges, necessitating the search for alternative therapies. This study evaluates the anticonvulsant activity and toxicological profile of Verbesina persicifolia leaf extracts. Methanolic and sequential fractions (hexane, dichloromethane, ethyl acetate, and methanol) were tested using [...] Read more.
Epilepsy is a chronic neurological disorder with significant treatment challenges, necessitating the search for alternative therapies. This study evaluates the anticonvulsant activity and toxicological profile of Verbesina persicifolia leaf extracts. Methanolic and sequential fractions (hexane, dichloromethane, ethyl acetate, and methanol) were tested using a pentylenetetrazole (PTZ)-induced seizure model in zebrafish (Danio rerio), measuring seizure latency, severity, and survival rates. Phytochemical screening confirmed the presence of flavonoids, alkaloids, and steroids, suggesting potential neuroactive properties. The hexane extracts significantly increased seizure latency and survival rates, with co-administration of hexane extract (5 µg/mL) and diazepam (35.5 µM) further enhancing these effects. Toxicity assessment in Artemia salina indicated low to moderate toxicity in methanolic extracts, while sequential fractions exhibited higher toxicity, particularly in hexane and ethyl acetate extracts. These findings suggest that V. persicifolia extracts exert anticonvulsant effects, likely through GABAergic modulation, and exhibit a favorable safety profile at therapeutic doses. The results support further investigations to isolate active constituents, confirm their mechanisms of action, and explore their potential as plant-derived anticonvulsant agents. Full article
(This article belongs to the Special Issue Phytochemistry, Pharmacology, and Toxicity of Medicinal Plants)
Show Figures

Figure 1

18 pages, 3658 KiB  
Article
Bioactive Metabolites from the Dusty Seeds of Gastrodia elata Bl., Based on Metabolomics and UPLC-Q-TOF-MS Combined with Molecular Network Strategy
by Yanduo Wang, Liwen Zhong, Huiqi Fang, Zhao Liu, Peng Wang, Longfei Li, Lin Chen and Gang Ding
Plants 2025, 14(6), 916; https://doi.org/10.3390/plants14060916 - 14 Mar 2025
Viewed by 363
Abstract
Orchids produce tiny, light seeds (dust-like seeds without endosperm) that rely on specific symbiotic fungi for successful germination. Plant roots often release small signaling molecules or bioactive compounds to attract arbuscular mycorrhizal (AM) fungi, promoting fungal growth and hyphal branching. However, until now, [...] Read more.
Orchids produce tiny, light seeds (dust-like seeds without endosperm) that rely on specific symbiotic fungi for successful germination. Plant roots often release small signaling molecules or bioactive compounds to attract arbuscular mycorrhizal (AM) fungi, promoting fungal growth and hyphal branching. However, until now, no such bioactive or signaling molecules have been identified in orchids that help recruit fungi for seed germination. In this study, we used metabolomics and UPLC-Q-TOF-MS/MS, combined with a molecular network approach, to explore potential bioactive/signaling molecules in the seeds of the achlorophyllous orchid Gastrodia elata Bl. Our analysis revealed the presence of amino acids, nucleotides, lipids, organic acids, saccharides, phospholipids, and lignanamides. Specifically, organic acids, saccharides, and lignanamides were shown to promote the growth of Mycena osmundicola, a fungus important for seed germination. Additionally, lignanamides inhibited the plant pathogen Fusarium oxysporum and exhibited strong antioxidant and anti-inflammatory activities. This is the first systematic identification of bioactive/signaling molecules in G. elata Bl. seeds, providing new insights into the symbiotic relationship between orchids and fungi. Full article
(This article belongs to the Special Issue Phytochemistry, Pharmacology, and Toxicity of Medicinal Plants)
Show Figures

Figure 1

Back to TopTop